These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35065059)

  • 1. Naringenin affords protection against lipopolysaccharide/D-galactosamine-induced acute liver failure: Role of autophagy.
    Ahmedy OA; Salem HH; Sayed NH; Ibrahim SM
    Arch Biochem Biophys; 2022 Mar; 717():109121. PubMed ID: 35065059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
    Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
    Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response.
    Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q
    Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
    Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
    Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy.
    Lv H; Fan X; Wang L; Feng H; Ci X
    Int J Biol Macromol; 2018 Nov; 119():240-248. PubMed ID: 30031824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice.
    He Y; Xia Z; Yu D; Wang J; Jin L; Huang D; Ye X; Li X; Zhang B
    Int Immunopharmacol; 2019 Mar; 68():171-178. PubMed ID: 30641432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antagonistic effect of tamoxifen against d-galactosamine/lipopolysaccharide-induced acute liver failure is associated with reactivation of hepatic nuclear factor-κB.
    Liu L; Zhao Y; Lin Y; Zhang R; Luo S; Ye P; Luo M
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):192-198. PubMed ID: 30721100
    [No Abstract]   [Full Text] [Related]  

  • 9. Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3.
    Xia Y; Wang P; Yan N; Gonzalez FJ; Yan T
    Cell Death Dis; 2021 Feb; 12(2):174. PubMed ID: 33574236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis.
    Lv H; An B; Yu Q; Cao Y; Liu Y; Li S
    Int J Biol Macromol; 2020 Jul; 155():1092-1104. PubMed ID: 31712142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
    Lyu Z; Ji X; Chen G; An B
    Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qingchangligan formula attenuates the inflammatory response to protect the liver from acute failure induced by d-galactosamine/lipopolysaccharide in mice.
    Zhang X; Ding J; Gou C; Wen T; Li L; Wang X; Yang H; Liu D; Lou J; Chen D; Ren F; Li X
    J Ethnopharmacol; 2017 Apr; 201():108-116. PubMed ID: 27833028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice.
    Gong X; Yang Y; Huang L; Zhang Q; Wan RZ; Zhang P; Zhang B
    Int Immunopharmacol; 2017 May; 46():124-132. PubMed ID: 28282576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A.
    Lv H; Yang H; Wang Z; Feng H; Deng X; Cheng G; Ci X
    Cell Death Dis; 2019 Apr; 10(4):313. PubMed ID: 30952839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 6 inhibitor ACY1215 offers a protective effect through the autophagy pathway in acute liver failure.
    Chen Q; Wang Y; Jiao FZ; Shi CX; Gong ZJ
    Life Sci; 2019 Dec; 238():116976. PubMed ID: 31634464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
    Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
    Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
    Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
    Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure.
    Shirozu K; Tokuda K; Marutani E; Lefer D; Wang R; Ichinose F
    Antioxid Redox Signal; 2014 Jan; 20(2):204-16. PubMed ID: 23758073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panaxynol from
    Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
    Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.